Lumeran, Jerald Kurt D.

HRN: 21-74-74  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/24/2025
CEFUROXIME 750MG (VIAL)
07/24/2025
07/31/2025
IV
640mg
Q8
AGE PCAP
Checking Initial Appropriateness 
07/25/2025
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
07/25/2025
07/31/2025
PO
5mL
BID X3days
Ascaris
Checking Initial Appropriateness 
07/27/2025
CEFTRIAXONE 1G (VIAL)
07/27/2025
08/03/2025
IV
1.9g
OD
AGE, PCAP
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: